Results 31 to 40 of about 251,532 (186)

INFLUENCE OF PHYSIOTHERAPY ON CLINICAL AND IMMUNOLOGICAL PARAMETERS IN CHILDREN WITH JUVENILE RHEUMATOID ARTHRITIS [PDF]

open access: yesСаратовский научно-медицинский журнал, 2008
Clinical and immunological status has been evaluated in 85 children with juvenile rheumatoid arthritis (RA) before and after physiotherapeutic procedures: electrophoresis with dimexid and magnetotherapy.
T.L. Nastausheva, L.T. Dmitrieva
doaj  

Treatment of juvenile rheumatoid arthritis [PDF]

open access: yesKorean Journal of Pediatrics, 2010
The systematic approach to pharmacologic treatment is typically to begin with the safest, simplest, and most conservative measures. It has been realized that the more rapidly inflammation is under control, the less likely it is that there will be ...
Kwang Nam Kim
doaj   +1 more source

Autoantibodies in the Pathogenesis, Diagnosis, and Prognosis of Juvenile Idiopathic Arthritis

open access: yesFrontiers in Immunology, 2019
Autoantibody production occurs in juvenile idiopathic arthritis (JIA) and numerous other autoimmune diseases. In some conditions, the autoantibodies are clearly pathogenic, whereas in others the roles are less defined.
Shawn A. Mahmud, B. Binstadt
semanticscholar   +1 more source

Type 1 diabetes associated with Hashimoto's thyroiditis and juvenile rheumatoid arthritis: a case report with clinical and genetic investigations

open access: yesPediatric Diabetes, 2010
Nagy KH, Lukacs K, Sipos P, Hermann R, Madacsy L, Soltesz G. Type 1 diabetes associated with Hashimoto's thyroiditis and juvenile rheumatoid arthritis: a case report with clinical and genetic investigations.
K. Nagy   +5 more
semanticscholar   +1 more source

Cytokine status and hemostasis disorders in children with juvenile idiopathic arthritis

open access: yesActa Biomedica Scientifica
Juvenile idiopathic arthritis is a chronic inflammatory joint disease in children under 16 years of age associated with pathological immune response to various antigens. Probable factors are infectious and immunogenetic.
M. V. Gomellya   +3 more
doaj   +1 more source

Issues of the pharmaceutical care of patients with juvenile rheumatoid arthritis

open access: yesZaporožskij Medicinskij Žurnal, 2013
The ways of the pharmaceutical care of juvenile rheumatoid arthritis on the base of the modern medical drugs and immunobiologic medications use were improved.
I. Yu. Revyatskyy
doaj   +1 more source

HDAC Inhibition in Rheumatoid Arthritis and Juvenile Idiopathic Arthritis

open access: yesMolecular Medicine, 2011
Rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA) are heterogeneous autoimmune diseases characterized by chronic joint inflammation. Methotrexate is used as the gold standard to treat rheumatoid arthritis, yet there are many patients in ...
J. Vojinović, N. Damjanov
semanticscholar   +1 more source

JUVENILE CHRONIC ARTHRITIS WITH EYE LESION

open access: yesНаучно-практическая ревматология, 2002
A bstract. Objective, to describe a series of pts with JRA/JCA and uveitis. Material and methods. The study included 81 pts with JRA and uveitis. There were 68 girls-84%, 13 boys-16%.
S O Salugina   +4 more
doaj   +1 more source

Biologic therapy of rheumatoid arthritis [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2009
Rheumatoid arthritis (RA) and juvenile idiopathic/rheumatoid arthritis (JIA) are chronic, inflammatory, systemic, auto-immune diseases characterized by chronic arthritis leading to progressive joint erosions.
Damjanov Nemanja, Vojinović Jelena
doaj   +1 more source

Experience of use of the anti-cytokine drug adalimumab in children with polyarticular seronegative junior arthritis living in the Samara region

open access: yesЛечащий Врач, 2023
Background. Juvenile idiopathic arthritis is the most common rheumatic disease in childhood. Adalimumab is the drug of choice for polyarthritis, HLA-B27-associated arthritis, psoriatic arthritis, as well as for the association of arthritis with ...
S. V. Plakhotnikova   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy